Circulating LPSs induce a potent inflammatory state through the Toll-like receptor 4 (TLR4) signaling pathway [17], which is involved in the development of metabolic diseases, such as obesity, insulin resistance, and cardiovascular disease. Here, TLR4 is linked to metabolic disease.